Compounds and compositions as protein kinase inhibitors
US8501758B2 · kind B2 · utility
31Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 27, 2010 |
| Grant date | Aug 6, 2013 |
| Priority date | — |
| Expiry date | Mar 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of B-Raf.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.